Sirnaomics Investor Relations Material
Latest events
H2 2024
27 Mar, 2025
H1 2024
30 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sirnaomics Ltd
Access all reports
Sirnaomics Ltd is a biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference (RNAi) therapeutics. The company specializes in developing RNA-based drugs for the treatment of diseases in areas such as oncology, fibrosis, and other serious conditions. Its platform integrates proprietary delivery technologies designed to enhance the targeting and effectiveness of RNAi-based treatments. Sirnaomics Ltd conducts research, clinical development, and regulatory activities as part of its product advancement strategy. The company is headquartered in Suzhou, China, and its shares are listed on the HKEX.
)
)
)